My prediction here is that for natural and totally understandable reasons, it will be hard to gauge the investability of international companies vs US startups.

My prediction here is that for natural and totally understandable reasons, it will be hard to gauge the investability of international companies vs US startups. So over a period of time, we might see prorata moving to US startups fairly naturally . Given the other issues around travel in a post-COVID world, this will might to a return to US centric portfolio allocation.